Dillon & Associates Inc. Reduces Position in Colgate-Palmolive (NYSE:CL)

Dillon & Associates Inc. trimmed its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 13.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 39,029 shares of the company’s stock after selling 5,947 shares during the quarter. Dillon & Associates Inc.’s holdings in Colgate-Palmolive were worth $3,122,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vest Financial LLC increased its holdings in Colgate-Palmolive by 25.1% in the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock valued at $29,498,000 after buying an additional 74,337 shares during the last quarter. Central Bank & Trust Co. grew its holdings in shares of Colgate-Palmolive by 22.1% during the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after purchasing an additional 250 shares during the last quarter. Dynamic Advisor Solutions LLC grew its holdings in shares of Colgate-Palmolive by 9.2% during the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock valued at $864,000 after purchasing an additional 910 shares during the last quarter. Sarasin & Partners LLP grew its holdings in shares of Colgate-Palmolive by 1.2% during the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock valued at $323,115,000 after purchasing an additional 49,980 shares during the last quarter. Finally, Cornerstone Wealth Management LLC grew its holdings in shares of Colgate-Palmolive by 2.5% during the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after purchasing an additional 172 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. StockNews.com lowered Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Stifel Nicolaus upped their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a report on Monday, April 29th. Evercore ISI upped their target price on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. Royal Bank of Canada boosted their price objective on Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Monday, April 29th. Finally, TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Three analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $92.35.

View Our Latest Report on CL

Insider Activity

In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider John W. Kooyman sold 3,497 shares of the business’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the sale, the insider now directly owns 3,181 shares in the company, valued at $297,328.07. The disclosure for this sale can be found here. In the last 90 days, insiders sold 89,209 shares of company stock worth $7,667,425. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE:CL traded down $0.40 on Friday, reaching $94.13. 4,135,238 shares of the company traded hands, compared to its average volume of 4,852,708. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $95.59. The company’s 50 day moving average is $89.81 and its 200-day moving average is $83.70. The stock has a market capitalization of $77.23 billion, a PE ratio of 29.79, a P/E/G ratio of 3.48 and a beta of 0.40. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the prior year, the firm earned $0.73 EPS. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. As a group, analysts anticipate that Colgate-Palmolive will post 3.53 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.12%. The ex-dividend date of this dividend was Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.